Phase I/II study of carboplatin with weekly ifostamide and docetaxel in recurrent or metastatic head and neck squamous cell cancers (HN-SCC).

被引：0
|
作者：
Chauhan, B [1 ]
Wanebo, H [1 ]
Rathore, R [1 ]
Chougule, P [1 ]
Kennedy, T [1 ]
Ready, N [1 ]
机构：
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5601
引用
收藏
页码：513S / 513S
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC).
    Rathore, R
    Chougule, P
    Wanebo, H
    Nadeem, A
    Radie-Keane, K
    Sikov, W
    Negri, P
    Kennedy, T
    Ready, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 513S - 513S
  • [2] Weekly Docetaxel in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Specenier, Pol
    Rasschaert, Marika
    Vroman, Philippe
    Van den Brande, Jan
    Dyck, Joke
    Schrijvers, Dirk
    Huizing, Manon T.
    Vermorken, Jan B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 472 - 477
  • [3] Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Hitt, R
    Amador, ML
    Quintela-Fandino, M
    Jimeno, A
    del Val, O
    Hernando, S
    Cortes-Funes, H
    CANCER, 2006, 106 (01) : 106 - 111
  • [4] Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Specenier, P.
    Rasschaert, M.
    Vroman, Ph
    ORAL ONCOLOGY, 2009, : 93 - 93
  • [5] Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Gedlicka, C
    Formanek, M
    Selzer, E
    Burian, M
    Kornfehl, J
    Fiebiger, W
    Cartellieri, M
    Marks, B
    Kornek, GV
    ONCOLOGY, 2002, 63 (02) : 145 - 150
  • [6] Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study
    Guntinas-Lichius, O.
    Appenrodt, S.
    Veelken, F.
    Krug, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [7] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
  • [8] Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck - A phase II multicenter study
    Labourey, Jean-Luc
    Cupissol, Didier
    Calais, Gilles
    Tourani, Jean-Marc
    Kohser, Frederic
    Borel, Christian
    Eymard, Jean-Christophe
    Germann, Nathalie
    Tubiana-Mathieu, Nicole
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 278 - 282
  • [9] Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer
    Guntinas-Lichius, O
    Appenrodt, S
    Veelken, F
    Krug, B
    LARYNGOSCOPE, 2006, 116 (04): : 613 - 618
  • [10] The triplet docetaxel, carboplatin and capecitabine in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN).
    Kattan, J
    Farhat, F
    Chahine, G
    Nasr, F
    Moukadem, W
    Younes, F
    Ghosn, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 521S - 521S
12345